Home Article Tandem receives authorization to distribute t:slim app in Canada

Tandem receives authorization to distribute t:slim app in Canada

By HME News Staff

Updated 9:22 AM CDT, Thu September 4, 2025

SAN DIEGO – Tandem Diabetes Care has received Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone and to wirelessly upload their pump data to the cloud-based Tandem Source platform. The app is expected to be available later this year. “This authorization demonstrates our dedication to expanding Tandem’s global offerings and delivering advanced technology to our Canadian customers,” said John Sheridan, president and CEO. “It showcases our team’s agility in meeting international standards and our commitment to offering innovative, integrated diabetes solutions.” The Tandem t:slim mobile app is a secure, user-friendly mobile application that, when paired with a t:slim X2 insulin pump, displays the user’s pump information on their personal smartphone. In addition to the ability to deliver and cancel a bolus, the mobile app displays the last 24 hours of glucose trends, pump status changes, and insulin therapy data, including basal and bolus deliveries and suspensions of insulin delivery.